First, it represents the largest retrospective cohort of Taiwanese patients with Turner syndrome treated with recombinant human growth hormone (rhGH) and estrogen replacement therapy (ERT) to date, spanning a 25-year period across three major medical centers. Here, GH1 is linked to Turner syndrome.